285 related articles for article (PubMed ID: 20027934)
1. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
McClain RW; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Dec; 8(12):1076-9. PubMed ID: 20027934
[TBL] [Abstract][Full Text] [Related]
2. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
3. Use and abuse of topical corticosteroids in infections of the skin and related structures.
Wong VK; Della Croce C; Schonfeld S; Mastrangelo AM; Lebwohl M
J Drugs Dermatol; 2003 Jun; 2(3):268-76. PubMed ID: 12848111
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
Stein L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus ointment: new preparation. Too many unknowns.
Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
[TBL] [Abstract][Full Text] [Related]
6. Peristomal dermatoses: a novel indication for topical steroid lotions.
Lyon CC; Smith AJ; Griffiths CE; Beck MH
J Am Acad Dermatol; 2000 Oct; 43(4):679-82. PubMed ID: 11004626
[TBL] [Abstract][Full Text] [Related]
7. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
9. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
10. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
[TBL] [Abstract][Full Text] [Related]
11. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
Pariser D
Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
[TBL] [Abstract][Full Text] [Related]
12. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
13. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.
Faurschou A; Wulf HC
Arch Dermatol; 2008 May; 144(5):620-4. PubMed ID: 18490588
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous mast cell depletion results from topical corticosteroid usage.
Lavker RM; Schechter NM
J Immunol; 1985 Oct; 135(4):2368-73. PubMed ID: 4031494
[TBL] [Abstract][Full Text] [Related]
15. [Oral therapy for atopic dermatitis in year 2000. Questionnaire Study to Boarding Members of Japanese Society for Allergology].
Aoki T; Kono T
Arerugi; 2003 Apr; 52(4):434-43. PubMed ID: 12754420
[TBL] [Abstract][Full Text] [Related]
16. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
17. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
18. [Local treatment with corticosteroids--limits on the duration of administration].
Zesch A
Hautarzt; 1990 Mar; 41(3):119-25. PubMed ID: 2188934
[TBL] [Abstract][Full Text] [Related]
19. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
